Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR
- 1 March 2000
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 7 (6), 458-463
- https://doi.org/10.1038/sj.gt.3301112
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 19 references indexed in Scilit:
- Immune response to green fluorescent protein: implications for gene therapyGene Therapy, 1999
- Molecular Evaluation of Biopsy and Autopsy Specimens from Patients Receiving in Vivo Retroviral Gene TherapyHuman Gene Therapy, 1999
- Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer CellsHuman Gene Therapy, 1998
- Quantitation of Host Cell DNA Contaminate in Pharmaceutical-Grade Plasmid DNA Using Competitive Polymerase Chain Reaction and Enzyme-Linked Immunosorbent AssayHuman Gene Therapy, 1998
- Internal Ribosomal Entry Site-Containing Retroviral Vectors with Green Fluorescent Protein and Drug Resistance MarkersHuman Gene Therapy, 1998
- Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a markerGene Therapy, 1997
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- Gene MarkingHuman Gene Therapy, 1996
- Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cellsNature Biotechnology, 1996
- T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patientsNature Medicine, 1996